Hip Osteonecrosis Workup

  • Author: Michael Levine, MD; Chief Editor: Carlos J Lavernia, MD, FAAOS   more...
 
Updated: May 1, 2012
 

Laboratory Studies

Lab tests have limited utility in the diagnosis of osteonecrosis, with exceptions as follows:

  • Sickle cell testing in African Americans
  • Lipid profile
  • Screening for coagulopathies -Protein S and protein C deficiencies, factor V Leiden disease
Next

Imaging Studies

Anteroposterior (AP) radiographs (see image below) and frog lateral radiographs of both hips are the primary diagnostic modalities.

Osteonecrosis, hip. Anteroposterior radiograph shoOsteonecrosis, hip. Anteroposterior radiograph showing Ficat stage III disease.

AP and frog lateral tomograms

  • Indicated if patients have evidence of disease on radiographs but have no collapse
  • Often helpful in staging

MRI

  • Sensitivity and specificity is greater than 98%, which is higher than all other modalities.
  • This study is ideal if x-ray findings are normal and clinical suspicion is high. MRI should be performed in all patients with osteonecrosis to assess the extent of the disease. Three-dimensional MRI scanning with image registration may be used to assess changes in lesion size.
  • MRI is recommended to identify bilateral disease when 1 hip has radiographic signs of disease and the other is normal (see image below). MRI showing osteonecrosis of right hip, normal lefMRI showing osteonecrosis of right hip, normal left hip.

Bone scanning (see image below)

Bone scan showing osteonecrosis of right hip. Bone scan showing osteonecrosis of right hip.
  • Helpful when x-ray findings are normal if MRI cannot be obtained
  • Low-cost alternative when index of suspicion is low
Previous
Next

Diagnostic Procedures

Core biopsy (see image below) and interosseous pressure measurement

Osteonecrosis, hip. Anteroposterior radiograph corOsteonecrosis, hip. Anteroposterior radiograph core biopsy.
  • An open biopsy of 10-mm core of bone from the femoral head can be used for diagnosis.
  • Measurement of interosseous pressure can be obtained before and after biopsy to confirm decompression of intraosseous space.

Venography

  • Injection of contrast under image intensification has been used as part of the functional evaluation of bone when measuring intraosseous pressure.
  • This can be used to confirm presence of the needle within the head and venous congestion.
Previous
Next

Histologic Findings

The first histologic findings are marrow and adipocyte necrosis. Next, liquefaction necrosis and interstitial edema occur. Pyknotic nuclei with empty lacunae are identified as osteocyte necrosis occurs. Eventually, the zone of necrosis is surrounded by repair tissue as revascularization proceeds. During this phase, the subchondral plate is weakened as resorption occurs faster than reformation, leading to subchondral collapse and eventual cartilage damage.

Previous
Next

Staging

Several radiographic staging systems are currently used.

  • Ficat classification[3]
    • Stage 0 - No pain, normal radiographic findings, abnormal bone scan or MRI findings
    • Stage I - Pain, normal x-ray findings, abnormal bone scan or MRI findings
    • Stage IIa - Pain, cysts and/or sclerosis visible on x-ray, abnormal bone scan or MRI findings, without subchondral fracture
    • Stage III - Pain, femoral head collapse visible on x-ray, abnormal bone scan or MRI findings, crescent sign (subchondral collapse) and/or step-off in contour of subchondral bone
    • Stage IV - Pain, acetabular disease with joint space narrowing and arthritis (osteoarthrosis) visible on x-ray, abnormal MRI or bone scan findings
  • Steinberg staging system[4]
    • Stage 0 - Normal or nondiagnostic radiographic, bone scan, and MRI findings
    • Stage I - Normal radiographic findings, abnormal bone scan and/or MRI findings
      • A - Mild: < 15% of head affected
      • B - Moderate: 15-30%
      • C - Severe: >30%
    • Stage II - Lucent and sclerotic changes in femoral head
      • A - Mild: < 15%
      • B - Moderate: 15-30%
      • C - Severe: >30%
    • Stage III - Subchondral collapse (crescent sign) without flattening
      • A - Mild: < 15% of articular surface
      • B - Moderate: 15-30%
      • C - Severe: >30%
    • Stage IV - Flattening of femoral head
      • A - Mild: < 15% of surface or < 2-mm depression
      • B - Moderate: 15-30% of surface or 2- to 4-mm depression
      • C - Severe: >30% of surface or >4-mm depression
    • Stage V - Joint narrowing and/or acetabular changes
      • A - Mild: Average of femoral head involvement as in stage IV and estimated acetabular
      • B - Moderate involvement
      • C - Severe
    • Stage VI - Advanced degenerative changes
  • International classification of osteonecrosis of the femoral head (Association Research Circulation Osseus [ARCO])[5]
    • Stage 0 - Bone biopsy results consistent with osteonecrosis; other test results normal
    • Stage I - Positive findings on bone scan, MRI, or both
      • A - < 15% involvement of the femoral head (MRI)
      • B - 15-30% involvement
      • C - >30% involvement
    • Stage II - Mottled appearance of femoral head, osteosclerosis, cyst formation, and osteopenia on radiographs; no signs of collapse of femoral head on radiographic or CT study; positive findings on bone scan and MRI; no changes in acetabulum
      • A - < 15% involvement of the femoral head (MRI)
      • B - 15-30% involvement
      • C - >30% involvement
    • Stage III - Presence of crescent sign lesions classified on basis of appearance on AP and lateral radiographs
      • A - < 15% crescent sign or < 2-mm depression of femoral head
      • B - 15-30% crescent sign or 2- to 4-mm depression
      • C - >30% crescent sign or >4-mm depression
    • Stage IV - Articular surface flattened; joint space shows narrowing; changes in acetabulum with evidence of osteosclerosis, cyst formation, and marginal osteophytes
Previous
 
 
Contributor Information and Disclosures
Author

Michael Levine, MD  Vice Chairman, Department of Orthopedic Surgery, Forbes Regional Hospital; Associate Clinical Professor of Orthopedic Surgery, Temple University School of Medicine.

Michael Levine, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Hip and Knee Surgeons, American Medical Association, Orthopaedic Research Society, Pennsylvania Medical Society, Pennsylvania Orthopaedic Society, and Phi Beta Kappa

Disclosure: Don Joy Surgical Consulting fee Consulting; glaxo smith kline Honoraria Speaking and teaching; covidien Consulting fee Consulting; orthomcneil Honoraria None

Coauthor(s)

Amar Rajadhyaksha, MD  Resident, Department of Orthopedic Surgery, New York Medical College

Disclosure: Nothing to disclose.

Specialty Editor Board

B Sonny Bal, MD  Associate Professor, Department of Orthopedic Surgery, University of Missouri-Columbia School of Medicine

B Sonny Bal, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Bonesmart.org None Online orthopaedic marketing and information portal; OrthoMind None Social networking for orthopaedic surgeons; Amedica Corporation Stock options and compensation Manufacturer of Orthopaedic Implants; BalBrenner LLC Ownership interest Consulting; Zimmer Royalty Consulting; Medtronic None Consulting; ConforMIS Consulting

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

James J McCarthy, MD, FAAOS, FAAP  Director, Division of Orthopedic Surgery, Cincinnati Children's Hospital; Professor, Department of Orthopedic Surgery, University of Cincinnati College of Medicine

James J McCarthy, MD, FAAOS, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Orthopaedic Surgeons, American Academy of Pediatrics, American Orthopaedic Association, Limb Lengthening and Reconstruction Society ASAMI-North America, Orthopaedics Overseas, Pediatric Orthopaedic Society of North America, Pennsylvania Medical Society, Pennsylvania Orthopaedic Society, and Philadelphia County Medical Society

Disclosure: Fixes-4-kids Ownership interest Consulting; Lippincott Williams and WIcins Royalty Editing textbook; OERHOPEDICS Royalty Editor

Dinesh Patel, MD, FACS  Associate Clinical Professor of Orthopedic Surgery, Harvard Medical School; Chief of Arthroscopic Surgery, Department of Orthopedic Surgery, Massachusetts General Hospital

Dinesh Patel, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Nothing to disclose.

Chief Editor

Carlos J Lavernia, MD, FAAOS  Adjunct Clinical Professor, Department of Orthopedic Surgery, University of Miami School of Medicine; Medical Director, Orthopedic Institute at Mercy Hospital

Carlos J Lavernia, MD, FAAOS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Hip and Knee Surgeons, Arthritis Foundation, Biomedical Engineering Society, Florida Orthopaedic Society, and Orthopaedic Research Society

Disclosure: Zimmer Stock Implant Designer

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Michael Mont, MD,to the development and writing of this article.

References
  1. Aaron RK. Osteonecrosis: etiology, pathophysiology, and diagnosis. In: Callahan JJ, Rosenberg AG, and Rubash HE. The Adult Hip. Philadelphia, Pa:. Lippincott-Raven Publishers;1998:451-66.

  2. Cenni E, Fotia C, Rustemi E, Yuasa K, Caltavuturo G, Giunti A, et al. Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors. Acta Orthop. Feb 2011;82(1):42-9. [Medline].

  3. Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg [Br]. Jan 1985;67(1):3-9. [Medline].

  4. Steinberg ME, Hayken GD, Steinberg DR. A new method for evaluation and staging of avascular necrosis of the femoral head. In: Arlet J, Ficat,P, Hungerford. Bone Circulation. Baltimore, Md: Williams and Wilkins;1984:398-403.

  5. ARCO Committee on Terminology and Staging. The ARCO perspective for reaching one uniform staging system for osteonecrosis. In: Schoutens pathologic conditions. New York, NY: Plenum Press;1993:375-80.

  6. Chen CH, Chang JK, Lai KA, Hou SM, Chang CH, Wang GJ. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum. May 2012;64(5):1572-8. [Medline].

  7. [Best Evidence] Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. Oct 2005;87(10):2155-9. [Medline].

  8. Wang CJ, Wang FS, Ko JY, Huang HY, Chen CJ, Sun YC, et al. Extracorporeal shockwave therapy shows regeneration in hip necrosis. Rheumatology (Oxford). Apr 2008;47(4):542-6. [Medline].

  9. Stiehl JB, Ulrich SD, Seyler TM, Bonutti PM, Marker DR, Mont MA. Bone morphogenetic proteins in total hip arthroplasty, osteonecrosis and trauma surgery. Expert Rev Med Devices. Mar 2008;5(2):231-8. [Medline].

  10. Jones KB, Seshadri T, Krantz R, Keating A, Ferguson PC. Cell-based therapies for osteonecrosis of the femoral head. Biol Blood Marrow Transplant. Oct 2008;14(10):1081-7. [Medline].

  11. Nadeau M, Séguin C, Theodoropoulos JS, Harvey EJ. Short term clinical outcome of a porous tantalum implant for the treatment of advanced osteonecrosis of the femoral head. Mcgill J Med. Jan 2007;10(1):4-10. [Medline].

  12. Stulberg BN, Davis AW, Bauer TW. Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin Orthop. Jul 1991;(268):140-51. [Medline].

  13. Tanzer M, Bobyn JD, Krygier JJ, Karabasz D. Histopathologic retrieval analysis of clinically failed porous tantalum osteonecrosis implants. J Bone Joint Surg Am. Jun 2008;90(6):1282-9. [Medline].

  14. Mont MA, Einhorn TA, Sponseller PD. The trapdoor procedure using autogenous cortical and cancellous bone grafts for osteonecrosis of the femoral head. J Bone Joint Surg Br. Jan 1998;80(1):56-62. [Medline].

  15. Beaty JH. Osteonecrosis. In: Orthopedic Knowledge. Update 6. Rosemont, Ill:. American Academy of Orthopedic Surgery;1999:460-5.

  16. Bradway JK, Morrey BF. The natural history of the silent hip in bilateral atraumatic osteonecrosis. J Arthroplasty. Aug 1993;8(4):383-7. [Medline].

  17. Kerboul M, Thomine J, Postel M. The conservative surgical treatment of idiopathic aseptic necrosis of the femoral head. J Bone and Joint Surg. 1974;56-B(2):291-96. [Medline].

  18. Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg. Jul-Aug 1999;7(4):250-61. [Medline].

  19. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. Mar 1995;77(3):459-74. [Medline].

  20. Petty W. Osteonecrosis: Strategies for treatment. In: Callahan, Rosenberg AG, and Rubashed HE. The Adult Hip. Philadelphia, Pa:. Lippincott-Raven Publishers;1998:467-84.

  21. Steinberg ME, Corces A, Fallon M. Acetabular involvement in osteonecrosis of the femoral head. J Bone Joint Surg Am. Jan 1999;81(1):60-5. [Medline].

  22. Stulberg BN, Bauer TW, Belhobek GH. A diagnostic algorithm for osteonecrosis of the femoral head. Clin Orthop. Dec 1989;(249):176-82. [Medline].

  23. Urbaniak JR, Harvey EJ. Revascularization of the femoral head in osteonecrosis. J Am Acad Orthop Surg. Jan-Feb 1998;6(1):44-54. [Medline].

Previous
Next
 
Osteonecrosis, hip. Anteroposterior radiograph showing Ficat stage III disease.
MRI showing osteonecrosis of right hip, normal left hip.
Bone scan showing osteonecrosis of right hip.
Osteonecrosis, hip. Anteroposterior radiograph core biopsy.
Osteonecrosis, hip. A radiograph of a limited femoral resurfacing performed for a collapsed femoral head with damaged femoral head cartilage and intact acetabular cartilage.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.